deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03626636

A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration

A Randomized Controlled, Double-Masked, Crossover Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration

Sponsor: Allegro Ophthalmics, LLC

Conditions Dry Age-related Macular Degeneration
Interventions Risuteganib Sham
Updated 8 times since 2018 Last updated: Jul 7, 2020 Started: Aug 1, 2017 Primary completion: Apr 4, 2019 Completion: Apr 4, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03626636, this PHASE2 trial focuses on Dry Age-related Macular Degeneration and remains completed. Sponsored by Allegro Ophthalmics, LLC, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshotActive Not Recruiting~Feb 2019 – ~Apr 2019 · 59 days · monthly snapshotActive Not Recruiting~Apr 2019 – ~Aug 2019 · 4 months · monthly snapshotActive Not Recruiting~Aug 2019 – ~Aug 2020 · 12 months · monthly snapshotActive Not Recruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  5. Aug 2019 — Aug 2020 [monthly]

    Active Not Recruiting PHASE2

▶ Show 3 earlier versions

  1. Apr 2019 — Aug 2019 [monthly]

    Active Not Recruiting PHASE2

  2. Feb 2019 — Apr 2019 [monthly]

    Active Not Recruiting PHASE2

  3. Sep 2018 — Feb 2019 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Allegro Ophthalmics, LLC
Data source: Allegro Ophthalmics, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations